News Focus
News Focus
Followers 84
Posts 1581
Boards Moderated 0
Alias Born 06/06/2012

Re: BioHedge post# 81411

Tuesday, 12/09/2014 7:32:25 PM

Tuesday, December 09, 2014 7:32:25 PM

Post# of 405181
I hear you
And thx for your continuing education for us IHUBers
Your posts are among the best
Sounding like broken record, but the "thought leaders" on this Board are impressive -- phooey to Industry know-it-alls and to smarty pants Ivy Grads... Street/I Bank Slaves
I'm more than happy to ride along in the wake of this boards Brights contributing (admittedly minimally) where I can
Don't know if any folks had a chance to rvw this resource further, but it's loaded w good stuff to my ex-mng consultant eyes. In a past life id be data mining the heck out of it

http://aspe.hhs.gov/sp/reports/2014/antibacterials/rpt_antibacterials.cfm#_Toc382830366

The image Figure 2 in above cited research in particular speaks to B and possibly K and P. Worth a look-see.

Figure 2: Drug Development Decision Tree Depicting Expected Net Present Value (ENPV) of Private Returns (Values in $ Million) for a Hypothetical New Molecule X [as in Brilacidin]

Can't wait for bottomline data coupled with FDA insight. Leo I'm thinking is gonna deliver the goods during this season of giving.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y